| Note* | 2018 $000 |
2017 $000 |
||
|---|---|---|---|---|
| Assets | Current assets | |||
|
Cash and cash equivalents |
38.1 | 29,306 | 31,220 | |
|
Restricted cash and cash equivalents |
23.0, 38.1 | 1,245 | 127 | |
|
Inventories |
24.0 | 6,752 | 5,489 | |
|
Receivables |
25.0 | 17,667 | 19,803 | |
|
Income tax receivable |
26.0,44.0 | - | 561 | |
|
Biological assets |
30.0 | 33,706 | 23,540 | |
|
Other assets |
27.0 | 600 | 1,008 | |
| Total current assets | 89,276 | 81,747 | ||
| Non-current assets | ||||
|
Property, plant and equipment and infrastructure |
28.0 | 29,023 | 26,842 | |
|
Deferred tax assets |
44.0 | - | 1,208 | |
|
Biological assets |
30.0 | 295,306 | 302,645 | |
|
Intangibles |
29.0 | 495 | 328 | |
| Total non-current assets | 324,824 | 331,023 | ||
| Total assets | 414,100 | 412,770 | ||
| Liabilities | Current liabilities | |||
|
Payables |
33.0 | 14,215 | 14,625 | |
|
Provisions |
35.0 | 8,350 | 8,827 | |
|
Deferred revenue |
36.0 | 1,789 | 1,678 | |
| Tax payable | 34.0, 44.0 | 6 | - | |
| Total current liabilities | 24,360 | 25,130 | ||
| Non-current liabilities | ||||
|
Payables |
33.0 | 3,460 | 4,698 | |
|
Provisions |
35.0 | 2,417 |
3,536 |
|
| Deferred tax liabilities | 44.0 | 211 | - | |
|
Deferred revenue |
36.0 | 13,362 | 14,628 | |
| Total non-current liabilities | 19,450 | 22,862 | ||
|
Total liabilities |
43,810 |
47,992 |
||
|
|
Net assets | 370,290 | 364,778 | |
| Equity | Equity | 37.0 | ||
|
Contributed equity |
343,541 | 342,241 | ||
|
Reserves |
10,575 | 10,748 | ||
|
Retained earnings / (Accumulated losses) |
16,174 | 11,789 | ||
|
Total equity |
370,290 | 364,778 |
As at 30 June 2018. The 'Statement of financial position' should be read in conjunction with the accompanying notes.